An open up-label examine was completed in 2016 in the UK to research the feasibility, safety and efficacy of psilocybin in dealing with patients with unipolar treatment-resistant depression with promising benefits; Even though the examine was modest and associated only twelve patients, seven of These patients achieved official criteria for remissio… Read More